Post-Marketing Surveillance Study of Adalimumab in Pediatric Chronic Severe Plaque Psoriasis Patients in Korea
Clinical trial NCT03925441 · COMPLETED
Trial details
- NCT number
- NCT03925441
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-06-25
- Primary completion
- 2019-08-06
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.